Michael King
Stock Analyst at EF Hutton
(1.03)
# 3,554
Out of 4,786 analysts
122
Total ratings
34.43%
Success rate
-15.63%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Michael King
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| APLM Apollomics | Maintains: Buy | $1,100 → $650 | $6.20 | +10,383.87% | 4 | Apr 1, 2024 | |
| SONN Sonnet BioTherapeutics Holdings | Assumes: Buy | $1,179 | $1.34 | +87,900.00% | 7 | Aug 23, 2023 | |
| LTRN Lantern Pharma | Reiterates: Buy | $11 | $3.54 | +210.73% | 10 | Aug 10, 2023 | |
| BMEA Biomea Fusion | Reiterates: Buy | $32 | $2.13 | +1,402.35% | 11 | Jun 26, 2023 | |
| JSPR Jasper Therapeutics | Reiterates: Buy | $69 | $4.30 | +1,493.02% | 10 | Jun 12, 2023 | |
| COEP Coeptis Therapeutics Holdings | Assumes: Buy | $200 | $9.37 | +2,034.47% | 7 | May 25, 2023 | |
| HOWL Werewolf Therapeutics | Assumes: Buy | $8.3 | $0.97 | +753.73% | 6 | May 25, 2023 | |
| REGN Regeneron Pharmaceuticals | Reiterates: Buy | $862 | $634.23 | +35.91% | 11 | May 1, 2023 | |
| EXEL Exelixis | Reiterates: Buy | $24 | $36.92 | -34.99% | 10 | Apr 28, 2023 | |
| OCEA Ocean Biomedical | Maintains: Buy | $10 → $17 | $0.05 | +31,381.48% | 3 | Apr 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $166 | $1.51 | +10,929.90% | 8 | Mar 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $42 | $10.64 | +294.74% | 5 | Feb 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $304 | $270.02 | +12.58% | 2 | Feb 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $123 → $116 | $7.11 | +1,531.50% | 6 | Feb 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $10 | $1.90 | +442.11% | 2 | Dec 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $500 → $560 | $0.53 | +105,680.13% | 2 | Mar 30, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $24 | $32.15 | -25.35% | 1 | Mar 23, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $1,000 → $800 | $0.75 | +106,000.80% | 2 | Mar 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $43 → $46 | $18.59 | +147.44% | 3 | Mar 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $98 → $96 | $29.30 | +227.65% | 6 | Mar 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $36 | $0.72 | +4,869.63% | 1 | Jan 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $12 | $0.26 | +4,531.42% | 1 | Dec 23, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $25 → $31 | $5.99 | +417.53% | 2 | Nov 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Outperform | $33 → $36 | $591.87 | -93.92% | 2 | Nov 13, 2017 |
Apollomics
Apr 1, 2024
Maintains: Buy
Price Target: $1,100 → $650
Current: $6.20
Upside: +10,383.87%
Sonnet BioTherapeutics Holdings
Aug 23, 2023
Assumes: Buy
Price Target: $1,179
Current: $1.34
Upside: +87,900.00%
Lantern Pharma
Aug 10, 2023
Reiterates: Buy
Price Target: $11
Current: $3.54
Upside: +210.73%
Biomea Fusion
Jun 26, 2023
Reiterates: Buy
Price Target: $32
Current: $2.13
Upside: +1,402.35%
Jasper Therapeutics
Jun 12, 2023
Reiterates: Buy
Price Target: $69
Current: $4.30
Upside: +1,493.02%
Coeptis Therapeutics Holdings
May 25, 2023
Assumes: Buy
Price Target: $200
Current: $9.37
Upside: +2,034.47%
Werewolf Therapeutics
May 25, 2023
Assumes: Buy
Price Target: $8.3
Current: $0.97
Upside: +753.73%
Regeneron Pharmaceuticals
May 1, 2023
Reiterates: Buy
Price Target: $862
Current: $634.23
Upside: +35.91%
Exelixis
Apr 28, 2023
Reiterates: Buy
Price Target: $24
Current: $36.92
Upside: -34.99%
Ocean Biomedical
Apr 27, 2023
Maintains: Buy
Price Target: $10 → $17
Current: $0.05
Upside: +31,381.48%
Mar 28, 2023
Reiterates: Buy
Price Target: $166
Current: $1.51
Upside: +10,929.90%
Feb 24, 2023
Reiterates: Buy
Price Target: $42
Current: $10.64
Upside: +294.74%
Feb 24, 2023
Reiterates: Buy
Price Target: $304
Current: $270.02
Upside: +12.58%
Feb 24, 2023
Maintains: Buy
Price Target: $123 → $116
Current: $7.11
Upside: +1,531.50%
Dec 16, 2022
Initiates: Buy
Price Target: $10
Current: $1.90
Upside: +442.11%
Mar 30, 2022
Maintains: Buy
Price Target: $500 → $560
Current: $0.53
Upside: +105,680.13%
Mar 23, 2022
Initiates: Buy
Price Target: $24
Current: $32.15
Upside: -25.35%
Mar 11, 2022
Maintains: Buy
Price Target: $1,000 → $800
Current: $0.75
Upside: +106,000.80%
Mar 8, 2022
Maintains: Buy
Price Target: $43 → $46
Current: $18.59
Upside: +147.44%
Mar 3, 2022
Maintains: Buy
Price Target: $98 → $96
Current: $29.30
Upside: +227.65%
Jan 10, 2022
Initiates: Buy
Price Target: $36
Current: $0.72
Upside: +4,869.63%
Dec 23, 2021
Initiates: Buy
Price Target: $12
Current: $0.26
Upside: +4,531.42%
Nov 5, 2021
Maintains: Buy
Price Target: $25 → $31
Current: $5.99
Upside: +417.53%
Nov 13, 2017
Maintains: Market Outperform
Price Target: $33 → $36
Current: $591.87
Upside: -93.92%